Categorynews

Global Active Pharmaceutical Ingredient (Captive API & Merchant API) Markets Report 2022 – ResearchAndMarkets.com

January 31, 2022 Off By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Active Pharmaceutical Ingredient (API) Market” report has been added to ResearchAndMarkets.com’s offering.

The surge in corona cases worldwide has played an essential role in active pharmaceutical ingredient manufacturers’ development over the forecast period.

The administration has done a molecule-by-molecule charting of active pharmaceutical ingredients (APIs) imported from China to uplift domestic construction and imports from third party suppliers in sight of the supply chain disruptions due to the COVID-19 pandemic. Pandemic has added a further difficulty as governments worldwide decided to boycott APIs manufactured in China.

Regional Analysis

North America currently leads the market for active pharmaceutical ingredients and is anticipated to continue its stronghold for a few more years due to the growing incidences of disease and rising aging population.

The European regional active pharmaceutical ingredient market is anticipated to account for a second principal market share through the forecast period.

The Asia Pacific active pharmaceutical ingredient market is assessed to be the fastest encouraging region in the worldwide active pharmaceutical ingredient market because of the commonness of quickly emerging markets are developing as core hubs for outsourcing drug manufacturing.

Key Developments

In 2020, Pfizer (US) signed a multiyear agreement with Gilead Sciences to manufacture and supply Gilead’s antiviral drug (Remdesivir) for the treatment of COVID-19.

In 2020, Novartis (Switzerland) acquired Aspen’s Japanese operations to strengthen its position in the global generics and off-patent medicines market. Novartis also entered into a manufacturing and supply agreement with Aspen.

In April 2020, Boehringer Ingelheim (Germany) acquired Northern Biologics, which focuses on therapeutic antibodies targeting the tumor microenvironment. This acquisition broadened Boehringer Ingelheim’s oncology product portfolio.

Key Players

Some of the key players operating in Active Pharmaceutical Ingredient (API) Market are

  • Aurobindo Pharma Limited
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • Boehringer Ingelheim International GmbH
  • Cipla Inc.
  • F. Hoffmann-La Roche AG
  • Pfizer Inc.
  • Merck & Co.
  • Teva Pharmaceutical Industries Ltd

Market Taxonomy

Business Mode

  • Captive API
  • Merchant API

Synthesis Type

  • Synthetic
  • Biotech

Type of Drug

  • Generic
  • Branded

Application

  • Cardiology
  • Pulmonology
  • Oncology
  • Ophthalmology
  • Neurology
  • Orthopedic
  • Other Applications

For more information about this report visit https://www.researchandmarkets.com/r/sqgfia

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900